FR2353285A1 - Medicament vasodilatateur coronarien perfectionne - Google Patents

Medicament vasodilatateur coronarien perfectionne

Info

Publication number
FR2353285A1
FR2353285A1 FR7528462A FR7528462A FR2353285A1 FR 2353285 A1 FR2353285 A1 FR 2353285A1 FR 7528462 A FR7528462 A FR 7528462A FR 7528462 A FR7528462 A FR 7528462A FR 2353285 A1 FR2353285 A1 FR 2353285A1
Authority
FR
France
Prior art keywords
compsn
angina pectoris
reduced side
showing
side effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7528462A
Other languages
English (en)
French (fr)
Other versions
FR2353285B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOMS LABORATOIRES
Original Assignee
DOMS LABORATOIRES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOMS LABORATOIRES filed Critical DOMS LABORATOIRES
Priority to FR7528462A priority Critical patent/FR2353285A1/fr
Publication of FR2353285A1 publication Critical patent/FR2353285A1/fr
Application granted granted Critical
Publication of FR2353285B1 publication Critical patent/FR2353285B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
FR7528462A 1975-09-17 1975-09-17 Medicament vasodilatateur coronarien perfectionne Granted FR2353285A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7528462A FR2353285A1 (fr) 1975-09-17 1975-09-17 Medicament vasodilatateur coronarien perfectionne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7528462A FR2353285A1 (fr) 1975-09-17 1975-09-17 Medicament vasodilatateur coronarien perfectionne

Publications (2)

Publication Number Publication Date
FR2353285A1 true FR2353285A1 (fr) 1977-12-30
FR2353285B1 FR2353285B1 (enrdf_load_stackoverflow) 1978-12-01

Family

ID=9160081

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7528462A Granted FR2353285A1 (fr) 1975-09-17 1975-09-17 Medicament vasodilatateur coronarien perfectionne

Country Status (1)

Country Link
FR (1) FR2353285A1 (enrdf_load_stackoverflow)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430766A1 (fr) * 1978-07-15 1980-02-08 Boehringer Sohn Ingelheim Forme retard de medicaments, comportant une enveloppe de diffusion poreuse insoluble
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
EP0076428A1 (en) * 1981-10-05 1983-04-13 Tanabe Seiyaku Co., Ltd. Microcapsules and method of preparing same
EP0032562B1 (de) * 1980-01-12 1984-03-14 Dr. Karl Thomae GmbH Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
EP0140255A3 (en) * 1983-10-14 1985-10-30 Sumitomo Chemical Company, Limited Sustained-release injections
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US5051262A (en) * 1979-12-07 1991-09-24 Elan Corp., P.L.C. Processes for the preparation of delayed action and programmed release pharmaceutical forms and medicaments obtained thereby
WO2002049651A1 (de) * 2000-12-19 2002-06-27 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
WO2002049650A3 (de) * 2000-12-19 2002-10-31 Merck Patent Gmbh Pharmazeutische formulierung enthaltend thienopyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
WO2002049649A3 (de) * 2000-12-19 2002-11-21 Merck Patent Gmbh Pharmazeutische formulierung enthaltend thienopyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate (2)
WO2005044244A3 (de) * 2003-11-07 2006-10-05 Univ Ernst Moritz Arndt Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430766A1 (fr) * 1978-07-15 1980-02-08 Boehringer Sohn Ingelheim Forme retard de medicaments, comportant une enveloppe de diffusion poreuse insoluble
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
US4726951A (en) * 1978-12-22 1988-02-23 Elan Corporation P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
US5051262A (en) * 1979-12-07 1991-09-24 Elan Corp., P.L.C. Processes for the preparation of delayed action and programmed release pharmaceutical forms and medicaments obtained thereby
EP0032562B1 (de) * 1980-01-12 1984-03-14 Dr. Karl Thomae GmbH Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
EP0076428A1 (en) * 1981-10-05 1983-04-13 Tanabe Seiyaku Co., Ltd. Microcapsules and method of preparing same
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US5021241A (en) * 1983-10-14 1991-06-04 Sumitomo Pharmaceuticals Company, Limited Long-term sustained-release preparation
EP0140255A3 (en) * 1983-10-14 1985-10-30 Sumitomo Chemical Company, Limited Sustained-release injections
WO2002049651A1 (de) * 2000-12-19 2002-06-27 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
WO2002049650A3 (de) * 2000-12-19 2002-10-31 Merck Patent Gmbh Pharmazeutische formulierung enthaltend thienopyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
WO2002049649A3 (de) * 2000-12-19 2002-11-21 Merck Patent Gmbh Pharmazeutische formulierung enthaltend thienopyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate (2)
WO2005044244A3 (de) * 2003-11-07 2006-10-05 Univ Ernst Moritz Arndt Verwendung von mrp4-inhibitoren zur behandlung und/oder prophylaxe kardiovaskulärer erkrankungen

Also Published As

Publication number Publication date
FR2353285B1 (enrdf_load_stackoverflow) 1978-12-01

Similar Documents

Publication Publication Date Title
FR2353285A1 (fr) Medicament vasodilatateur coronarien perfectionne
NL7607720A (nl) Werkwijze voor de bereiding van een loslaatmiddel en voorwerpen met een dergelijk loslaatmiddel.
USD242641S (en) Ghost figure doll
NL185278B (nl) Werkwijze voor de bereiding van een lichtgevend pyrotechnisch preparaat.
USD247434S (en) Staff locator
AU505899B2 (en) 16 phencxy frosta 4, 5, 13 trienoic acid derivatives
USD244182S (en) Camper shell
NL7601117A (nl) Werkwijze voor de bereiding van acetyleenderi- vaten van aminozuren.
NL180766C (nl) Werkwijze voor de bereiding van een grondlaagbekledingspreparaat, alsmede gevormd voortbrengsel, bekleed met een dergelijk preparaat.
AU506606B2 (en) Articles for providing sustained release of water-soluble chemicals
USD242933S (en) Pipe sculpture
NL178889B (nl) Werkwijze voor de bereiding van een in water onoplosbaar enzym-preparaat.
USD245673S (en) Clock
NL189291C (nl) Werkwijze voor de bereiding van een natrium- of kaliumzout van 3,3-dimethyl-2-oxoboterzuur.
NL7507119A (nl) Werkwijze voor de bereiding van een hydroxylamine- zout.
USD242613S (en) Boat trailer tongue support or the like
NL7705380A (nl) Werkwijze voor de bereiding van onverzadigde carbonzuren.
NL168214C (nl) Werkwijze voor het bereiden van een beta-dihalogeenethenylcyclopropaancarbonzuurderivaat.
USD243865S (en) Game target
USD247355S (en) Sculpture
NL7609223A (nl) Werkwijze voor de bereiding van een prostaan derivaat.
NL7613331A (nl) Werkwijze voor de bereiding van een fosfoleen-1- -galcogenide.
NL7611052A (nl) Veiligheidsondersteuningssysteem voor de vleugeldragende steunen van een draag- vleugelboot.
USD249058S (en) After bath dryer
USD243356S (en) Toy animal figure and rider

Legal Events

Date Code Title Description
ST Notification of lapse